Concepedia

Peiguo Cao

PC

Statistics

Publications

37

Citations

2.3K

H-Index

24

Active since

2011

Affiliations

Third Xiangya Hospital(Current)

Central South University

Hunan Cancer Hospital

Zhejiang Cancer Hospital

Sun Yat-sen University

Peiguo Cao is an author at Third Xiangya Hospital specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2023

37

Publications

37

Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

Jin Li, Shukui Qin, Rui‐Hua Xu et al. · JAMA · 2018 · 378 citations · Full text

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Shengxiang Ren, Jianhua Chen, Xingxiang Xu et al. · Journal of Thoracic Oncology · 2021 · 293 citations

, , +8

miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α

Jianda Zhou, Dan Xu, Huiqing Xie et al. · Cancer Biology & Therapy · 2015 · 99 citations · Full text

SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival

Jia‐Lin Liu, Qing-hai Zeng, Peiguo Cao et al. · Oncogene · 2018 · 95 citations

, , +9

1–5 of 37